Concord Biotech Limited is an R&D based Biotechnology company, having focus on the fermentation, semi-synthetic and synthesis based products. Since its inception in 2000, Concord has recorded an excellent growth through diversification and process improvements. Having state-of-the-art US FDA & EUGMP approved facility; Concord is a professionally managed globally recognised supplier of fermentation based API’s and enzyme & offers services in biotechnology area like strain improvement & contract fermentation/ manufacturing.
The existing portfolio of products includes API’s in the immunosuppressant, antibiotic, Oncology , Anti-Obesity, hypolipemic segments and enzymes. However, with the expertise in the field of biotechnology and chemistry, the R&D team at Concord is working towards adding new products to the product basket.
|
|
|
|
|
501-1,000 employees
View all Concord Biotech Limited employees
|
|
|
Biotechnology
|
|
|
1482-1486, Trasad Road,, Dholka, Ahmedabad, Gujarat 387810, IN
|
|
|
2000
|
|
|
Global Presence, Contract Research And Manufacturing, Fermentation Api's, Usfda & Eugmp Approved Facility
|
Baiju Varghese is the CEO of Concord Biotech Limited. To contact Baiju Varghese email at [email protected].
The decision makers in Concord Biotech Limited are Anoop Dixit, Devang Bhatt, Dharnidhar Mistri, etc. Click to Find Concord Biotech Limited decision makers emails.
Concord Biotech Limited specializes in contract research and manufacturing services, focusing on fermentation, semi-synthetic, and synthesis-based products. The company provides a range of services including process development, scale-up, and commercial manufacturing of Active Pharmaceutical Ingredients (APIs). Their facilities are USFDA and EUGMP approved, ensuring compliance with international quality standards.
Concord Biotech serves a variety of industries, primarily focusing on the pharmaceutical and biotechnology sectors. Their expertise in fermentation and synthesis allows them to cater to clients involved in the development of therapeutics, including antibiotics, anti-cancer agents, and other critical medications. The company also supports clients in the agrochemical and nutraceutical industries.
Yes, Concord Biotech has extensive experience in regulatory affairs and can assist clients with the preparation and submission of regulatory documents. Their team is well-versed in the requirements of various regulatory bodies, including the USFDA and EMA, and can provide guidance throughout the submission process to ensure compliance and expedite approvals.
The USFDA and EUGMP approvals signify that Concord Biotech's manufacturing facilities and processes meet stringent international quality and safety standards. These certifications enhance the company's credibility and reliability as a partner for pharmaceutical companies, ensuring that the products manufactured are safe, effective, and of high quality.
Concord Biotech employs a robust quality management system that encompasses all aspects of its operations, from research and development to manufacturing. The company conducts rigorous testing and validation processes, adheres to Good Manufacturing Practices (GMP), and continuously monitors its processes to ensure that all products meet the highest quality standards.
Partnering with Concord Biotech for contract manufacturing offers several advantages, including access to state-of-the-art facilities, expertise in fermentation and synthesis technologies, and a commitment to quality and compliance. Additionally, Concord's global presence allows for efficient supply chain management and the ability to meet diverse client needs across different markets.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.